FDAnews
www.fdanews.com/articles/85017-life-sciences-are-luring-venture-capital

LIFE SCIENCES ARE LURING VENTURE CAPITAL

March 3, 2006

A healthy increase in venture- capital funding of medical-device companies has helped lift overall investments in life-sciences industries, even as biotechnology deals have tailed off. Companies that make artificial joints, heart stents and other devices are attracting VC dollars because investors see rising demand for such products as the U.S. population ages and people live longer. An active mergers-and-acquisitions market among device companies — including Boston Scientific's pending $27 billion purchase of Guidant — also has fueled VC interest in the sector.
The Star-Ledger